Disclosure:Benjamin H Holland has no conflicts of interest to declare. Robert J Applegate has served on the advisory board and as a consultant for Abbott Vascular and has received research grants from Abbott Vascular, St Jude Medical and Terumo Corporation.
Correspondence Details:Robert J Applegate, Section of Cardiology, Wake Forest School of Medicine, Medical Centre Boulevard, Winston-Salem, NC 27157-1045, US. E: bapplega@wfubmc.edu
Copyright Statement:
The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.
Abstract
Femoral access remains a vital route for many cardiac and non-cardiac procedures, including those involving the use of large delivery systems. In the common femoral artery access is extremely important to minimise complications and optimise use of closure devices. Dissatisfaction with haemostasis achieved by manual compression stimulated development of VCDs that provide quick and effective haemostasis after sheath removal. Despite shortening time to haemostasis and ambulation, a debate still rages regarding their overall contribution to reducing complications and healthcare costs.
To view the full article, please click on the PDF icon.
